Link address : http://www.prnewswire.com/news-releases/sillajen-announces-collaboration-with-the-national-cancer-institute-for-development-of-combination-therapy-with-sillajens-pexastimogene-devacirepvec-pexa-vec-oncolytic-immunotherapy-300505741.html
Targeting, Attacking, and Eradicating Cancers®
